Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01309581 · ClinicalTrials.gov registry record · NA
Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression
A NA study, sponsored by James Murrough.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01309581: Clinical Trial NA study, sponsored by James Murrough.
NCT01309581 is a NA study that was terminated before completion, run by James Murrough. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01309581, a NA study, was terminated before completion, sponsored by James Murrough.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The primary objectives of this study are to investigate the potential for ketamine anesthesia to increase the antidepressant efficacy of Electroconvulsive therapy (ECT) and to decrease acute ECT-induced adverse cognitive effects.
Primary Outcome
The HDRS-24 is used to rate depressive symptoms. This instrument is considered one of the "gold standard" clinician-rated instruments for depressive symptoms. We have established procedures for the maintenance of inter-rater reliability.
Interventions
- DRUG Ketamine
- DRUG Methohexital
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2010-04 |
| Est. Completion | 2010-10 |
| Phase | NA |
Why NCT01309581 stopped before completion
NCT01309581 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Ketamine is the first listed.
NCT01309581 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01309581 about?
NCT01309581 is a clinical study titled "Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression". The primary objectives of this study are to investigate the potential for ketamine anesthesia to increase the antidepressant efficacy of Electroconvulsive therapy (ECT) and to decrease acute ECT-induced adverse cognitive effects.
What is the current status of trial NCT01309581?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2010-04. Estimated completion is 2010-10.
What interventions are being tested in trial NCT01309581?
The interventions under investigation include: Ketamine (DRUG), Methohexital (DRUG).
Who is sponsoring clinical trial NCT01309581?
This trial is sponsored by James Murrough, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01309581's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia